Curative Biotechnology Inc (CUBT)

[conix]

Microcaps are ALWAYS going to be a bumpy ride. Always. They have more challenges in advancing their business plans. Biotechs, IT, cannabis, whatever.

It is why MOST microcap investors TRADE them--perhaps keeping a core position for the long run.

And if you trade with savvy, you may be able to accumulate a larger core position financed by short term trading.

Of course, there will be taxes and there will be the risk that you sold RIGHT BEFORE a huge spike in the stock from an unexpected positive piece of news. You have to be able to accept being "wrong" in selling some of your stock too soon. Or not buying more (or "enough") when the stock turns up again.

There have been some traders here that had HUGE unrealized gains and apparently did not sell any stock. Having come relatively late here, I have followed this board. I own stock--and I an underwater. But my due diligence on CUBT's ocular therapies, coupled with the NIH-funded trials, will keep me in. There is a certain vetting required before the NIH ever decides to fund a company's trials. They do not care if the company has an office. They are interested in important facts --like who owns the rights to the formulations. What preliminary clinical data is available. How promising and efficacious the treatment (s) being studied.

Just a few thoughts.

GLTA